AMURA THERAPEUTICS LTD has a total of 118 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are INTERMUNE INC, RHIZEN PHARMACEUTICALS S A and SIGNAL PHARM LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 23 | |
#2 | EPO (European Patent Office) | 19 | |
#3 | WIPO (World Intellectual Property Organization) | 18 | |
#4 | United Kingdom | 15 | |
#5 | Canada | 9 | |
#6 | Australia | 6 | |
#7 | Brazil | 5 | |
#8 | China | 5 | |
#9 | Israel | 5 | |
#10 | New Zealand | 4 | |
#11 | South Africa | 4 | |
#12 | Hong Kong | 2 | |
#13 | Republic of Korea | 1 | |
#14 | Mexico | 1 | |
#15 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Biotechnology | |
#6 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Quibell Martin | 90 |
#2 | Watts John Paul | 53 |
#3 | Ramjee Manoj Kumar | 12 |
#4 | Flinn Nicholas Sean | 12 |
#5 | Wang Yikang | 11 |
#6 | Nally James | 10 |
#7 | Ray Peter Christopher | 8 |
#8 | Standen Michael | 6 |
#9 | Watts John P | 5 |
#10 | Turnell William Gordon | 5 |
Publication | Filing date | Title |
---|---|---|
WO2009087379A2 | Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases | |
GB0809776D0 | Compounds | |
GB0808669D0 | Compounds | |
GB0804702D0 | Compounds | |
GB0804701D0 | Compounds | |
GB0800338D0 | Compounds | |
AU2006277710A1 | Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles | |
GB0614053D0 | Compounds | |
GB0614042D0 | Compounds | |
GB0614037D0 | Compounds | |
GB0614073D0 | Compounds | |
GB0614044D0 | Compounds | |
GB0614040D0 | Process | |
GB0614052D0 | Compounds | |
GB0614046D0 | Compounds | |
GB0517279D0 | Biologically active compounds | |
GB0501008D0 | Method of producing conjugate vaccines | |
WO2004007501A1 | Biologically active compounds | |
US2005158370A1 | Charge-balanced chemoselective linkers | |
AU2003201663A1 | Enzyme substrates for the determination of activity of staphylococcus sp. extracellular protease |